Unlocking the Unknown With Metagenomics

·26 min·2 clips

A 40-year-old patient with progressing symptoms was finally diagnosed with a fatal parasitic disease by metagenomic sequencing.

The episode begins with host Dr. Bobbi Pritt introducing the show and two segments. Dr. Bill Maurice joins first to provide updates on clinical diagnostics policy. He explains PAMA, the Protection and Access to Medicare Act, which uses market-based pricing for lab tests but has flawed data collection skewing reimbursement lower for hospitals. Maurice outlines three strategies to address this: the Results Act for long-term reform, a bridge act for short-term relief, and administrative action by CMS. He notes the political challenges but encourages listener engagement through professional organizations. After Maurice's segment, Pritt transitions to the deep dive with Dr. Trish Simner. Simner shares her background, including her fellowship at Mayo Clinic and her clinical interests in antimicrobial resistance and next-generation sequencing. She then details the metagenomic sequencing test for cerebral spinal fluid. The process involves extracting all nucleic acid, preparing DNA and RNA libraries, sequencing, and using bioinformatics to identify microbial reads while ignoring human DNA. Simner explains the test is used when standard methods fail and highlights a case study: a 40-year-old patient from Cameroon with unresolved symptoms was diagnosed with Trypanosoma brucei, a fatal parasitic disease, via metagenomics. She discusses advances that enabled clinical use, such as method standardization and automated bioinformatics. Looking forward, Simner mentions automation, expanding to other sample types like plasma, and leveraging ignored data for insights into host response, microbiome, and antimicrobial resistance. Pritt wraps up by summarizing takeaways and promoting the next episode.

As heard by us

A clear tour from diagnostics policy to metagenomic sequencing in cerebral spinal fluid.

The episode moves from a clinical diagnostics policy discussion into a careful look at metagenomic sequencing of cerebral spinal fluid for meningitis and encephalitis. Dr. Bobbi Pritt leads the conversation, Dr. Bill Maurice covers the PAMA update, and Dr.

Read the full review in PlayNext →

Why you'd press play

For when you want the lab method, the PAMA backdrop, and the sequencing pipeline in one place.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Answers from the Lab